FOXO3 and cancer: In this context, nuclear translocation of released FOXO3a from 14-3-3 by PI3K inhibitor induces cytoprotective autophagy in PIK3CA-mutant cancer cells, leading to the improved anti-cancer efficacy of PI3K inhibitor when combined with autophagy inhibition.